Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website

Incyte Corp

Incyte Corp reported $178.62M in Pre-Tax Profit for its fiscal quarter ending in December of 2022.

Pre Tax Profit Change
Acadia Pharmaceuticals ACAD:US USD -44939000 4.05M
Aceragen Inc IDRA:US USD -11055000 20.19M
Agenus AGEN:US USD -70893000 3.21M
Agios Pharmaceuticals AGIO:US USD -81018000 117.54M
Alnylam Pharmaceuticals ALNY:US USD -172362000 34.66M
Bluebird Bio BLUE:US USD 21.24M 11.1M
CTI Biopharma CTIC:US USD -13422000 4.04M
Exelixis EXEL:US USD 48.28M 79.7M
Intercept Pharmaceuticals ICPT:US USD -31881000 14.34M
Ionis Pharmaceuticals IONS:US USD -113000000 81M
Lumos Pharma Inc. NLNK:US USD -7346000 914K
MacroGenics MGNX:US USD -38009000 50.81M
Merck & Co MRK:US USD 4.48B 411M
Mirati Therapeutics MRTX:US USD -184586000 17.63M
Nektar Therapeutics NKTR:US USD -137081000 80.54M
Neurocrine Biosciences NBIX:US USD -103300000 221.2M
PTC Therapeutics PTCT:US USD -134990000 21.32M
Sarepta Therapeutics SRPT:US USD -512710000 411.4M
Seattle Genetics SGEN:US USD -170113000 26.28M
Ultragenyx Pharmaceutical RARE:US USD -163477000 10.19M